Once you understand where quantum computing may help, the next question is: which scientific or operational bottleneck should you tackle first? This session moves from possibility to practical use cases across the biotech and healthcare value chain. From molecular simulation and protein structure to biomanufacturing and disease classification. Drawing on recent IonQ work with AstraZeneca, Centre for Commercialization for Regenerative Medicine (CCRM), Kipu Quantum, and quantum-enhanced AI, we’ll examine how hybrid quantum-classical workflows are being tested against real problems today. Attendees will learn how to identify quantum-suitable workloads, distinguish near-term experiments from longer-term opportunities, and leave with a sharper shortlist of use cases for their own organization.